Month: April 2021
-
Concrete Mfring Processes Win CO2 Conversion Challenge
Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products.
-
Challenge Trial Testing Covid-19 Reinfection
A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus.
-
Infographic – Israel Halts Covid-19 Spread with Vaccines
Israel is emerging as the world’s leader in vaccinating its population, and seeing results in declines of new Covid-19 cases.
-
AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.
-
Lilly Asks FDA to Revoke Covid-19 Therapy Clearance
Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.
-
Synthetic DNA Company Raises $24M in Early Funds
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round.
-
Mobile App Studied to Measure Kidney Disease Anemia
A smartphone app designed to non-invasively estimate hemoglobin levels is being assessed for its ability to measure anemia in chronic kidney disease patients.
-
Nine Campuses Join Rural Food Research Fund
Nine universities in the U.S. are taking part in a program supporting research and entrepreneurs developing food and agricultural solutions in rural areas.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.